Many of the growth factors have been approved for treatment of human diseases. Erythropoietin (EPO) is used on a considerable scale for the treatment of anaemia. EPO is also used to stimulate red blood cell production in kidney dialysis or cancer patients. Interleukin-2, in conjunction with LAK cells, is being used for cancer therapy.
Similarly, granulocyte macrophage colony stimulating factor and granulocyte colony stimulating factor are used to accelerate neutrophil recovery after chemotherapy or bone marrow transplantation. Several other growth factors have been/are likely to be approved for similar and other applications.



